Want to see ANAB full AI Analyst Report?
AnaptysBio (ANAB) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Rosnilimab | Ulcerative Colitis | Phase II | Active Not Recruiting | A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) | Nov 07, 2023 | ― |
| Rosnilimab | Rheumatoid Arthritis | Phase II | Active Not Recruiting | A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) | Sep 11, 2023 | ― |
| Anb032 | Atopic Dermatitis Eczema | Phase II | Terminated | This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD). | Jun 06, 2023 | ― |
| Imsidolimab | Acne Vulgaris | Phase II | Completed | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | Apr 20, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Rosnilimab | Phase II | Ulcerative Colitis | Active Not Recruiting | A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) | Nov 07, 2023 | ― |
| Rosnilimab | Phase II | Rheumatoid Arthritis | Active Not Recruiting | A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) | Sep 11, 2023 | ― |
| Anb032 | Phase II | Atopic Dermatitis Eczema | Terminated | This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD). | Jun 06, 2023 | ― |
| Imsidolimab | Phase II | Acne Vulgaris | Completed | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | Apr 20, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AnaptysBio (ANAB) have in its pipeline
AnaptysBio ANAB is currently developing the following drugs: Rosnilimab, Anb032, Imsidolimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
